34 research outputs found
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling
- Author
- Abdel-Maksoud
- Adams
- Altman
- Anderson
- Arias
- Arsenault
- Arsenault
- Assmann
- Athyros
- Baigent
- Balk
- Barzi
- Bertolini
- Bittner
- Bland
- Bloomfield
- Boekholdt
- Bos
- Bossuyt
- Bowman
- British Cardiac Society
- British Heart Foundation (BHF)
- Brown
- Bruno
- Cambien
- Cannon
- Capewell
- Carleton
- Chowdhury
- Clarke
- Clarke
- Clarke
- Clinical Practice Research Datalink (CPRD)
- ClinRisk Subversion Repository
- Colhoun
- Colivicchi
- Cooper
- Cooper
- Cooper
- Cremer
- CTSV
- Curtis
- Davey Smith
- Davidson
- de Lemos
- De Simone
- De Stavola
- Deedwania
- Del Mar
- Demacker
- Department of Health (DH)
- Department of Health (DH)
- Department of Health (DH)
- Desai
- Dhaliwal
- Doll
- Dontas
- Downs
- Dratva
- Dunder
- Eliasson
- Emberson
- Emerging Risk Factors Collaboration
- Emerging Risk Factors Collaboration
- Emerging Risk Factors Collaboration
- European Prospective Investigation into Cancer and Nutrition-Norfolk study
- Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults
- Fellstrom
- Finegold
- Friedewald
- Frost
- Frost
- Fukushima
- Ganga
- Garcia-Palmieri
- Gerber
- Gigante
- Giorda
- GISSI Prevenzione Investigators
- Glasziou
- Glasziou
- Glasziou
- Goldbourt
- Golomb
- Greenland
- Greving
- Grover
- Grover
- Hackam
- Hamaguchi
- Hamer
- Hayden
- Heart Foundation and Cardiac Society of Australia and New Zealand
- Heart Protection Study Collaborative Group
- Heart Protection Study Collaborative Group
- Higgins
- Higgins
- Hippisley-Cox
- HM Treasury
- Holme
- Houterman
- Howell
- HPS2-THRIVE
- Hu
- Hughes
- Ingelsson
- Irwig
- Iso
- Jardine
- Jeffs
- Jiang
- Joint Formulary Committee
- Jonsdóttir
- Kadoglou
- Kappelle
- Karpe
- Keenan
- Keil
- Kiechl
- Kinosian
- Kjekshus
- Klausen
- Knopp
- Koren
- Kyzas
- Lakka
- Lan
- Langsted
- LaRosa
- Law
- Leckie
- Lu
- Mainous
- Manickam
- Matthews
- McKinney
- McMurray
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Meisinger
- Menotti
- Mihaylova
- Mizuno
- Mohler
- Montori
- Morris
- Moschetti
- Moss
- Naci
- Naci
- National Institute for Health and Care Excellence (NICE)
- National Institute for Health and Care Excellence (NICE)
- National Institute for Health and Care Excellence (NICE)
- National Institute for Health and Care Excellence (NICE)
- National Institute for Health and Care Excellence (NICE)
- National Institute for Health and Care Excellence (NICE)
- Nazir
- Nedeljkovic
- NHS Business Services Authority
- NHS Centre for Reviews and Dissemination University of York
- NHS Choices
- NHS Choices
- NHS Choices
- NHS Choices
- NHS Employers
- Nissen
- Office for National Statistics (ONS)
- Okamura
- Oke
- Oke
- Orsini
- Ortolá
- Palma
- Palmieri
- Parish
- Parker
- Parmar
- Pedersen
- Pedersen
- Peeters
- Perel
- Perk
- Pignone
- Pocock
- Preiss
- Prentice
- Preventive Cardiology Information System Database Cohort Study
- Primary Prevention Cohort Study of the Japan Lipid Intervention Trial
- Prospective Studies Collaboration (PSC)
- Psaty
- Qizilbash
- Raggi
- Rancho Bernardo Study
- Rasmussen
- Ray
- Reilly
- Ridker
- Ridker
- Ridker
- Riley
- Robinson
- Rose
- Sacks
- Sai
- Saito
- Salomaa
- Sasaki
- Sato
- Sattar
- Scandinavian Simvastatin Survival Study Group
- Schatz
- Schmermund
- Schwartz
- Scottish Intercollegiate Guidelines Network (SIGN)
- Secondary Prevention Cohort Study of the Japan Lipid Intervention Trial
- Semba
- Sever
- Sever
- Shai
- Shai
- Shalev
- Shaper
- Shepherd
- Shepherd
- Shepherd
- Sierra-Johnson
- Simes
- Simons
- Smilde
- Smith
- Smith
- Sniderman
- Sola
- South West Yorkshire Area Prescribing Committee (SWYAPC)
- St-Pierre
- Stampfer
- Stanek
- StataCorp
- Stein
- Stevens
- Stevens
- Stone
- Stone
- Strachan
- Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group
- Sweetnam
- Takahashi
- Takahashi
- Taskinen
- Taylor
- Taylor
- Tehran University of Medical Sciences
- Teramoto
- The Lancet Editorial
- The LIPID Study Group
- The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
- The R Core Team
- The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators
- Thompson
- Ting
- Tohidi
- Townsend
- Trusler
- Tully
- Unal
- United States Preventive Services Task Force
- Upmeier
- Verschuren
- Wald
- Walley
- Ward
- Watkins
- Wei
- Weijenberg
- White
- White
- Wilczynski
- Williams
- Wilson
- Woodward
- Yarnell
- Yokokawa
- Zandbergen
- Zatonski
- Zhang
- Publication venue
- 'National Institute for Health Research'
- Publication date
- Field of study
Gerontology and Geriatric Medicine
- Publication venue
- 'Wiley'
- Publication date
- Field of study
NHS R & D achievements and future challenges
- Author
- Publication venue
- 'Wiley'
- Publication date
- Field of study
Critical appraisal of trials for validation of ‘risk-guided’ cardiovascular disease prevention therapy
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
Lighting the vascular fuse - late surgical attrition in older patients
- Author
- Publication venue
- 'Wiley'
- Publication date
- Field of study
The Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Atrial Fibrillation
- Author
- Publication venue
- 'S. Karger AG'
- Publication date
- Field of study
Interferon antibodies: do they alter the beneficial effects of beta-interferon upon relapse rate in multiple sclerosis?
- Author
- Bertolotto A
- Bornstein MB
- European Study Group on Interferon b-1b in Secondary Progressive MS.
- Hartung HP
- Jacobs LD
- Johnson KP
- Panitch H
- Peter Rudge
- Polman C
- Pozzilli C
- PRISMS (Prevention of Relapses and Disability by Interferon b-1a Subcutaneously in Multiple Sclerosis) Study Group
- Rudick RA
- Sorensen PS
- SPECTRIMS (Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon b-1a in Multiple Sclerosis) Study Group
- The IFNB Multiple Sclerosis Study Group
- The IFNB Multiple Sclerosis Study Group
- The Once Weekly Interferon for MS Study Group (OWIMS)
- Wolinsky JS
- Yudkin PL
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
- Author
- Austin
- Comi
- Confavreux
- D'Agostino
- D'Agostino
- De Stefano
- De Stefano
- European Study Group on Interferon Beta-1b in Secondary Progressive MS
- Jacobs
- Jacobs
- Kappos
- Kappos
- Kern
- Kinkel
- Kuhlmann
- Kurtzke
- Kurtzke
- Lin
- McDonald
- Mechati
- Normand
- Noseworthy
- O'Riordan
- Poser
- PRISMS (Prevention of Relapses and Disability by Interferon b-1a Subcutaneously in Multiple Sclerosis) Study Group
- Rubin
- Runmarker
- Schwid
- Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group
- The IFNB Multiple Sclerosis Study Group
- The PRISMS (Prevention of Relapses and Disability by Interferon-b-1a Subcutaneously in Multiple Sclerosis) Study Group
- Tintoré
- Trapp
- Trojano
- Trojano
- Trojano
- Weinshenker
- Yanovitzky
- Publication venue
- 'Wiley'
- Publication date
- Field of study
Major haemorrhagic complications during oral anticoagulant therapy in a Danish Population-based cohort
- Author
- ASPECT (Anticoagulatnts in the Secondary Prevention of Events in Coronary Thrombosis) Research Group
- Atrial Fibrillation Investigators
- Clayton
- EAFT (European Atrial Fibrillation Trial) Study Group
- Fihn
- Gottlieb
- Gustaffsson
- Landefeld
- Landefeld
- Launbjerg
- Levine
- Lip
- Lundstrom
- Meer
- Nielsen
- Palareti
- Peftitti
- Phillips
- Raiford
- Schulaman
- StateCorp
- Taylor
- Publication venue
- 'Wiley'
- Publication date
- Field of study
The pathogenesis of multiple sclerosis: is it really a primary inflammatory process?
- Author
- Bitsch A
- Brex PA
- Coles AJ
- Comi G
- Confavreux C
- Dalton CM
- de Jong BA
- De Stefano N
- Ebers GC.
- European Study Group on Interferon beta-1b in Secondary Progressive MS.
- European Study Group on Interferon beta-1b in Secondary Progressive Mutiple Sclerosis
- F G Maggs
- Ferguson B
- Gravel C
- Ingle GT
- J Palace
- Karlik S
- Kremenchutzky M
- Li DK
- Liu C
- Lucchinetti C
- Moalem G
- Multiple Sclerosis Collaborative Research Group
- Neumann H.
- North American Study Group
- Paolillo A
- Parry A
- PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group
- Rapalino O
- Rice GPA
- Rocca MA
- Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group
- Serpe CJ
- Streit WJ
- The Copolymer 1 Multiple Sclerosis Study Group
- The IFNB Multiple Sclerosis Study Group
- The Multiple Sclerosis Collaborative Research Group (MSCRG)
- Thompson AJ
- Trapp BD
- Yan Q
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study